PATENT CLAIM ANALYSIS

Application Number: 15773454
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "364000"]

Abstract:
The present invention is directed to pharmaceutical compositions of an inhibitor of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders.

Claim (Index 31):
The method of any one of  claims 1  to  21  and  28 , wherein dosage regimen comprises about 200 mg on a free base basis of Compound 1, or a pharmaceutically acceptable salt thereof, which is administered twice daily.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 93.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15093420', '16061597', '13294711', '14661191', '14033117']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7888968126079864
- 35 USC 102 Novelty (BERT): 0.5391435196668982
- Combined Prediction Score: 0.7639214833138775
- Mean Citation Score: 260.49462800000003
- Max Citation Score: 267.73694
- Similarity Product: 169.546762624017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test